Literature DB >> 22887476

Why do some depressed outpatients who are not in remission according to the hamilton depression rating scale nonetheless consider themselves to be in remission?

Mark Zimmerman1, Jennifer Martinez, Naureen Attiullah, Michael Friedman, Cristina Toba, Daniela A Boerescu.   

Abstract

BACKGROUND: In treatment studies of depression, remission is typically defined narrowly-based on scores on symptom severity scales. Patients treated in clinical practice, however, define the concept of remission more broadly and consider functional status, coping ability, and life satisfaction as important indicators of remission status. In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we examined how many mildly symptomatic depressed patients in ongoing treatment who did not score in the remission range on the 17-item Hamilton Depression Rating Scale (HAMD) nonetheless considered themselves to be in remission from their depression. Among the mildly symptomatic HAMD nonremitters, we compared the demographic and clinical characteristics of patients who did and did not consider themselves to be in remission.
METHODS: We interviewed 274 psychiatric outpatients diagnosed with DSM-IV major depressive disorder who were in ongoing treatment. The patients completed measures of psychosocial functioning and quality of life.
RESULTS: Approximately one-quarter of the patients scoring 8-12 on the HAMD considered themselves to be in remission. Compared to patients who did not consider themselves to be in remission, the remitters reported significantly better quality of life, less functional impairment due to depression, higher positive mental health scores, and better coping ability. DISCUSSION: Some patients who do not meet symptom-based definitions of remission nonetheless consider themselves to be in remission. The findings raise caution in relying exclusively on symptom-based definitions of remission to guide treatment decision making in clinical practice.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22887476     DOI: 10.1002/da.21987

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  12 in total

1.  Toward a Quantification of Anhedonia: Unified Matching Law and Signal Detection for Clinical Assessment and Drug Development.

Authors:  Oanh T Luc; Diego A Pizzagalli; Brian D Kangas
Journal:  Perspect Behav Sci       Date:  2021-05-19

2.  In pursuit of full recovery in major depressive disorder.

Authors:  Vicent-Gil M; Serra-Blasco M; Navarra-Ventura G; Trujols J; Balanzá-Martínez V; Portella Mj; Cardoner N
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-09       Impact factor: 5.760

3.  Dysfunctional Reward Processing in Depression.

Authors:  Roee Admon; Diego A Pizzagalli
Journal:  Curr Opin Psychol       Date:  2015-08-01

4.  A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults.

Authors:  Roger S McIntyre; Søren Lophaven; Christina K Olsen
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-30       Impact factor: 5.176

5.  Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study.

Authors:  Alonso Montoya; Jeremie Lebrec; Karen Mary Keane; Irene Fregenal; Antonio Ciudad; Ángel Moríñigo; Luis Agüera-Ortiz; Irene Romera; Inmaculada Gilaberte; Mark Zimmerman
Journal:  BMC Psychiatry       Date:  2016-10-19       Impact factor: 3.630

6.  Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.

Authors:  F Hieronymus; J F Emilsson; S Nilsson; E Eriksson
Journal:  Mol Psychiatry       Date:  2015-04-28       Impact factor: 15.992

7.  Validity of clinically significant change classifications yielded by Jacobson-Truax and Hageman-Arrindell methods.

Authors:  Fiona R Ronk; Geoffrey R Hooke; Andrew C Page
Journal:  BMC Psychiatry       Date:  2016-06-06       Impact factor: 3.630

8.  Corticostriatal pathways contribute to the natural time course of positive mood.

Authors:  Roee Admon; Diego A Pizzagalli
Journal:  Nat Commun       Date:  2015-12-07       Impact factor: 14.919

9.  Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review.

Authors:  P L de Zwart; B F Jeronimus; P de Jonge
Journal:  Epidemiol Psychiatr Sci       Date:  2018-05-17       Impact factor: 6.892

10.  Empirical validation of a touchscreen probabilistic reward task in rats.

Authors:  Brian D Kangas; Lisa M Wooldridge; Oanh T Luc; Jack Bergman; Diego A Pizzagalli
Journal:  Transl Psychiatry       Date:  2020-08-13       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.